Literature DB >> 7564094

Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies.

M Leboulleux1, B Lelongt, B Mougenot, G Touchard, R Makdassi, A Rocca, L H Noel, P M Ronco, P Aucouturier.   

Abstract

Kidney tubule dysfunction and lesions are frequent complications of myeloma, related to unknown properties of the monoclonal light chain. We have analyzed protease sensitivity and binding properties of urinary light chains from four patients with Fanconi's syndrome, 12 with cast nephropathy, and four control patients without myeloma-associated tubulopathy. All light chains were normal-sized, monomeric and/or dimeric, and none was N-glycosylated. Kinetic studies of light chain digestion by pepsin and the lysosomal enzyme cathepsin B showed the generation of a protease-resistant 12 kDa fragment, corresponding to the V domain of the kappa chain in the four Fanconi's syndrome patients; in two out of four the V domain was also completely resistant to trypsin. Western and dot blots revealed similar patterns of reactivity of light chains from patients with the Fanconi's syndrome towards other light chains. Properties of cast-nephropathy light chains were more heterogeneous but clearly differed from those of Fanconi's syndrome: (i) 9 out of 12 were of the lambda-type; (ii) only four yielded a transient 12 kDa fragment after cathepsin B digestion, but all showed some resistance to proteolysis of the entire molecule or a fragment thereof to at least one protease, at variance with control light chains; (iii) they displayed various patterns of reactivity with other light chains; (iv) 7 out of 12 reacted specifically with Tamm-Horsfall protein (THP) by ELISA, in contrast with those of Fanconi's syndrome. In one patient who presented with cast nephropathy and the Fanconi's syndrome, the light chain exhibited both partial resistance of the V kappa domain to cathepsin B and the highest reactivity with THP.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564094     DOI: 10.1038/ki.1995.269

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

1.  Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients.

Authors:  M Vignon; V Javaugue; M P Alexander; K El-Karoui; A Karras; D Roos-Weil; B Royer; B Asli; B Knebelmann; G Touchard; A Jaccard; B Arnulf; F Bridoux; N Leung; J P Fermand
Journal:  Leukemia       Date:  2016-07-20       Impact factor: 11.528

2.  Renal impairment in multiple myeloma: presenting features in different departments.

Authors:  Ni Li; Yongman Lv; Hongbing Zeng; Fan He; Ying Yao; Xiaofeng He
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

3.  Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients.

Authors:  Luis M Blancas-Mejía; Emily B Martin; Angela Williams; Jonathan S Wall; Marina Ramirez-Alvarado
Journal:  Biophys Chem       Date:  2017-09-01       Impact factor: 2.352

4.  The reduced expression of proximal tubular transporters in acquired Fanconi syndrome with κ light chain deposition.

Authors:  Akihiro Tojo; Kensuke Asaba; Satoshi Kinugasa; Yoichiro Ikeda; Yukako Shintani; Masashi Fukayama; Masaomi Nangaku
Journal:  Med Mol Morphol       Date:  2015-07-04       Impact factor: 2.309

5.  Light Chain Proximal Tubulopathy: Clinical and Pathologic Characteristics in the Modern Treatment Era.

Authors:  Michael B Stokes; Anthony M Valeri; Leal Herlitz; Abdullah M Khan; David S Siegel; Glen S Markowitz; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2015-09-15       Impact factor: 10.121

6.  Megalin knockout mice as an animal model of low molecular weight proteinuria.

Authors:  J R Leheste; B Rolinski; H Vorum; J Hilpert; A Nykjaer; C Jacobsen; P Aucouturier; J O Moskaug; A Otto; E I Christensen; T E Willnow
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 7.  Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold.

Authors:  Sandhya Manohar; Samih H Nasr; Nelson Leung
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

Review 8.  Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias.

Authors:  Shveta S Motwani; Leal Herlitz; Divya Monga; Kenar D Jhaveri; Albert Q Lam
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

9.  Impaired Lysosomal Function Underlies Monoclonal Light Chain-Associated Renal Fanconi Syndrome.

Authors:  Alessandro Luciani; Christophe Sirac; Sara Terryn; Vincent Javaugue; Jenny Ann Prange; Sébastien Bender; Amélie Bonaud; Michel Cogné; Pierre Aucouturier; Pierre Ronco; Frank Bridoux; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2015-11-27       Impact factor: 10.121

Review 10.  Animal models of monoclonal immunoglobulin-related renal diseases.

Authors:  Christophe Sirac; Guillermo A Herrera; Paul W Sanders; Vecihi Batuman; Sebastien Bender; Maria V Ayala; Vincent Javaugue; Jiamin Teng; Elba A Turbat-Herrera; Michel Cogné; Guy Touchard; Nelson Leung; Frank Bridoux
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.